Effects of Exenatide on Obesity and Appetite in Overweight Patients With Prader-Willi Syndrome.
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2016
At a glance
- Drugs Exenatide (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- 27 Sep 2016 Status changed from active, no longer recruiting to completed.
- 26 Jul 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 26 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.